| DIRECT COMPETITOR COMPARISON | |
| ACUS | ALKS | BMY | Pvt1 | Industry | | Market Cap: | N/A | 817.82M | 50.28B | N/A | N/A | | Employees: | N/A | 570 | 35,000 | 46,0001 | N/A | | Qtrly Rev Growth (yoy): | N/A | 1.80% | 4.40% | N/A | N/A | | Revenue (ttm): | N/A | 295.19M | 21.14B | 17.30B1 | N/A | | Gross Margin (ttm): | N/A | 84.83% | 72.39% | N/A | N/A | | EBITDA (ttm): | N/A | 116.61M | 6.32B | N/A | N/A | | Oper Margins (ttm): | N/A | 32.44% | 26.65% | N/A | N/A | | Net Income (ttm): | N/A | 80.25M | 3.79B | N/A | N/A | | EPS (ttm): | N/A | 0.842 | 1.933 | N/A | N/A | | P/E (ttm): | N/A | 10.25 | 13.13 | N/A | N/A | | PEG (5 yr expected): | N/A | N/A | 2.51 | N/A | N/A | | P/S (ttm): | N/A | 2.77 | 2.38 | N/A | N/A |
|
| ALKS = Alkermes, Inc. | | BMY = Bristol-Myers Squibb Co. | | Pvt1 = GE Healthcare (privately held) | | 1 = As of 2008 |
| NEWS ON DIRECT COMPETITORS | |
| | BMY | | WHO issues new recommendations for HIV patients Sun 7:02pm -
at Reuters | | | BMY | | 8 HealthCare Stocks With 3%+ Dividends Sun 12:52am -
at Seeking Alpha | | | BMY | | [$$] Jim Cramer's Best Blogs Sat, Nov 28 -
at RealMoney by TheStreet.com | | | BMY | | TradingMarkets 7 Stocks You Need to Know for Monday Fri, Nov 27 -
TradingMarkets.com | | | BMY | | A Mostly Meaningless FDA Approval Fri, Nov 27 -
at Motley Fool | | | BMY | | Biotech Bargains for Your Portfolio Fri, Nov 27 -
at Motley Fool | | | ALKS | | 4 Platform Drugmakers to Invest In Tue, Nov 24 -
at Motley Fool | | | ALKS | | [$$] The Ascending Trend Line Breaks Fri, Nov 20 -
at RealMoney by TheStreet.com | | | ALKS | | Should You Buy It? Alkermes Thu, Nov 19 -
RealMoney by TheStreet.com | | | ALKS | | Good News for Alkermes' Pipeline Wed, Nov 18 -
Zacks.com | | | ALKS | | Tuesday's Big Gainers on Heavy Volume Wed, Nov 18 -
at Seeking Alpha | | | ALKS | | [$$] Activity Jumps in Biotech and Drug Firms Tue, Nov 17 -
at The Wall Street Journal Online | | | ALKS | | Alkermes Begins Trials for ALKS 33 Tue, Nov 17 -
at Fox Business | | | All Headlines for these symbols... |
|
|
|